HIV PrEP: Deploying Strategies for Equitable Preventive Care
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Click Here to Manage Email Alerts
Overview
Provider Statement
This continuing education activity is jointly provided by
and 
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Activity Description
HIV remains a significant public health challenge, particularly in high-risk populations. Pre-exposure prophylaxis (PrEP) has proven to be highly effective in preventing HIV transmission, yet it remains underutilized, with less than 25% of eligible individuals receiving this preventive therapy. The US Centers for Disease Control and Prevention (CDC) released updated guidelines in 2021, recommending that all sexually active adults and adolescents be informed about PrEP. Despite these guidelines, barriers such as lack of knowledge among clinicians, patient discomfort in discussing sexual history, and logistical concerns like cost and insurance coverage, hinder the broader adoption of PrEP. Specific populations, including young men who have sex with men (MSM) from racial or ethnic minority groups and those in the Southern United States, are particularly affected by low PrEP uptake. In this CE activity, expert faculty discuss the latest guideline recommendations on assessing patient HIV risk and eligibility for PrEP. They also evaluate best practices for initiating conversations with patients regarding the efficacy, safety, and appropriate use of PrEP as well as discussing the disparities and barriers that hinder its uptake.
Target Audience
The intended audience for this activity is primary care providers, infectious disease specialists, pharmacists, nurse practitioners, physician associates, and other healthcare professionals involved in the management of sexually active adults and adolescents.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Employ the latest guideline recommendations to assess patient risk for HIV acquisition and eligibility for PrEP.
- Initiate discussions with patients regarding the availability, efficacy, safety, and appropriate use of HIV PrEP.
- Outline disparities in HIV PrEP use related to age, race, gender, and other key social determinants of health.
Activity Chair
Charlotte-Paige Rolle, MD, MPH
Director of Research Operations,
Orlando Immunology Center
Orlando, FL
Adjunct Assistant Professor of Global Health,
Emory Rollins School of Public Health
Atlanta, GA
Faculty
Renata Arrington-Sanders, MD, MPH, ScM
Chief of Adolescent Medicine, Craig-Dalsimer Division of Adolescent Medicine
Children's Hospital of Philadelphia
University of Pennsylvania
Philadelphia, PA
Associate Professor
Louisiana State University Health Sciences Center
New Orleans, LA
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS
Linda A. Giarraputo, BS, PA-C
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participants who opt-in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.
Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid until August 30, 2025. PAs should only claim credit commensurate with the extent of their participation.
This program is acceptable for 1.50 contact hour of ACPE Continuing Education Credit. The ACPE Universal Program Number is JA0006104-9999-24-079-H02-P, effective 8/31/2024. This is a knowledge-based activity, and there is no fee to attend.
Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.
This enduring material is approved for 1 year from the date of original release, August 31, 2024, to August 30, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 out of the 5 the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate, AAPA Category 1 CME certificate, or Statement of Pharmacy Credit.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Renata Arrington-Sanders, MD, MPH, ScM
No relevant financial relationships to disclose.
Meredith E. Clement, MD
Advisor: ViiV
Independent Research Contractor: Gilead, ViiV
Charlotte-Paige Rolle, MD, MPH
Advisor: Gilead, ViiV
Consultant: Gilead, ViiV
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.
Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.
Vindico Medical Education and American Academy of HIV Medicine staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this CE activity is available upon request. Requests should include the activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education and American Academy of HIV Medicine continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education or American Academy of HIV Medicine. Neither Vindico Medical Education, American Academy of HIV Medicine, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com